Kit and method for detecting genes related to individualized medication for depression
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 广州海思医疗科技有限公司
- Publication Date
- 2019-08-23
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of gene detection, in particular to a kit and method for detecting genes related to individualized medication for depression. Background technique
[0002] Depression, also known as depressive disorder, is a common mental illness. According to statistics from the World Health Organization, by 2020, depression will become the second leading disease after heart disease. At present, more than 300 million people in the world are suffering from depression. The prevalence rate of depression in China is 6.1%, which is 3 percentage points higher than the global average, and the incidence rate has been increasing year by year in recent years. It is converted according to the incidence rate of 6.1%. , domestic depression patients have reached 90 million.
[0003] At present, the most effective means of treating depression is drug therapy, but it is still in the stage of trial and error, and the efficacy and adverse ...